References
- McGrathJSahaSChantDWelhamJSchizophrenia: a concise overview of incidence, prevalence, and mortalityEpidemiol Rev200830677618480098
- McCabeRSaidiMPriebeSPatient-reported outcomes in schizophreniaBr J Psychiatry Suppl200719150S212818019040
- NaberDMoritzSLambertMImprovement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugsSchizophr Res200150798811378316
- MarderSSubjective experiences on antipsychotic medications: synthesis and conclusionsActa Psychiatr Scand Suppl2005427434615877721
- SinghMMKaySRDysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosisBiol Psychiatry19791427729438865
- HoganTPAwadAGEastwoodRA self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychol Med1983131771836133297
- AwadAGSubjective response to neuroleptics in schizophreniaSchizophr Bull1993196096187901897
- WeidenPRapkinBMottTRating of medication influences (ROMI) scale in schizophreniaSchizophr Bull1994202973107916162
- NaberDA self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variablesInt Clin Psychopharmacol199510Suppl 31331388866775
- KampmanOLehtinenKLassilaVLeinonenEPoutanenOKoivistoAAttitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaireSchizophr Res20004522323411042440
- ThompsonKKulkarniJSergejewAAReliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychosesSchizophr Res20004224124710785582
- VorugantiLAwadAGPersonal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophreniaSchizophr Res200256374612084418
- BarberáMSanjuánJMunárrizMNovellaESantiagoCSimóMSubjective experience with antipsychotics:quantitative evaluationActas Esp Psiquiatr200634287294 Spanish16991016
- SirisSGDepression in schizophrenia: perspective in the era of “Atypical” antipsychotic agentsAm J Psychiatry20001571379138910964850
- MajadasSOlivaresJGalanJDiezTPrevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophreniaCompr Psychiatry2011 Epub May 27, 2011
- Schennach-WolffRObermeierMSeemüllerFEvaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleActa Psychiatr Scand201112322823821029053
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: Fourth Edition; Text RevisionWashington, DCAmerican Psychiatric Association2000
- SanjúanJHaroJMMaurinoJDíezTBallesterosJValidation of the Spanish version of the Subjective Well-being under Neuroleptic Scale (SWN-K) in patients with schizophreniaMed Clin (Barc)2011 Epub May 13, 2011
- AddingtonDAddingtonJMaticka-TyndaleEJoyceJReliability and validity of a depression rating scale for schizophrenicsSchizophr Res199262012081571313
- KontaxakisVPHavaki-KontaxakiBJStamouliSSMargaritiMMColliasCTChristodoulouGNComparison of four scales measuring depression in schizophrenic inpatientsEur Psychiatry20001527427710951613
- SarróSDuenasRMRamírezNCross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for SchizophreniaSchizophr Res20046834935615099616
- BurnsTEvolution of outcome measures in schizophreniaBr J Psychiatry Suppl2007191S1618019037
- US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth Qual Life Outcomes200647917034633
- KimJHAnnJHKimMJRelationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychoticsJ Clin Pharm Ther20113617217821366646
- HunterRCameronRNorrieJUsing patient-reported outcomes in schizophrenia: The Scottish schizophrenia outcomes studyPsychiatr Serv20096024024519176419